Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression-Reference-Cited by-同舟云学术

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Published:2015-07 Issue:11 Volume:51 Page:1435-1443
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Puzanov Igor,Amaravadi Ravi K.,McArthur Grant A.,Flaherty Keith T.,Chapman Paul B.,Sosman Jeffrey A.,Ribas Antoni,Shackleton Mark,Hwu Patrick,Chmielowski Bartosz,Nolop Keith B.,Lin Paul S.,Kim Kevin B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

2. Detection of B-RAF and N-RAS mutations in human melanoma;Goydos;J Am Coll Surg,2005

3. Analysis of BRAF mutation in primary and metastatic melanoma;Libra;Cell Cycle,2005

4. PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells;Halaban;Pigment Cell Melanoma Res,2010

5. PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas;Lee;Pigment Cell Melanoma Res,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells;Cell Communication and Signaling;2024-05-22

2. Design, synthesis, anticancer and in silico assessment of 8-caffeinyl chalcone hybrid conjugates;RSC Advances;2024

3. Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation;BMC Cancer;2023-10-23

4. Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma;Current Medicinal Chemistry;2023-10-19

5. Extracellular vesicles promote migration despite vemurafenib treatment in malignant melanoma cells;2023-08-21